Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-13-052761
Filing Date
2013-07-01
Accepted
2013-07-01 21:25:12
Documents
1
Period of Report
2013-06-19

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 6714
  Complete submission text file 0001104659-13-052761.txt   9340
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 259 RADNOR CHESTER ROAD SUITE 140 RADNOR PA 19087
MERIDIAN VENTURE PARTNERS II LP (Reporting) CIK: 0001109507 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 13946290

Mailing Address 259 N. RADNOR-CHESTER ROAD SUITE 130 RADNOR PA 19087
Business Address 259 N. RADNOR-CHESTER ROAD SUITE 130 RADNOR PA 19087 610-254-2999
Meridian Venture Partners II, Co. (Reporting) CIK: 0001580169 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1213
Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 13946288

Mailing Address 259 N. RADNOR-CHESTER ROAD SUITE 130 RADNOR PA 19087
Business Address 259 N. RADNOR-CHESTER ROAD SUITE 130 RADNOR PA 19087 610-254-2999
Meridian Venture Partners II GP, L.P. (Reporting) CIK: 0001580170 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1213
Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 13946289